David Sinclair· PhD
Mouse results look promising... but there’s a lot of work to do.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Mouse results look promising... but there’s a lot of work to do.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
NMN extends lifespan in C57BL/6J mice, but other promising longevity molecules do not. Many other promising molecules extend lifespan in other species, which means that one species and one breed of mouse should not decide the fate of any therapy